BioSpace News Archive

Shorla Oncology today announced the commercial launch of the company’s oncology drug, Nelarabine Injection, for the treatment of T-cell Acute Lymphoblastic Leukemia (T-ALL) and T-cell Lymphoblastic Lymphoma (T-LBL) in adult and pediatric patients aged one year and older whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens.

Altamira Therapeutics Ltd. (NASDAQ:CYTO) (“Altamira” or the “Company”), a company dedicated to addressing unmet medical needs, today provided a business update and reported its full year 2022 financial results ended December 31, 2022.

Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) announced today that its management team will participate in the Wells Fargo 2023 Medtech Innovation Spotlight Series on Monday, May 22, 2023.

Cytek Biosciences, Inc., a leading cell analysis solutions company, announced that it has shipped its 100thCytek Aurora CS system.

Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today six presentations supporting its gene editing, gene therapy and GTx-mAb programs at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting.

OncoSec Medical Incorporated (NASDAQ: ONCS) (the Company or OncoSec) today announced a Type C meeting held with the US Food and Drug Administration (FDA) on May 15, 2023.

Korio, Inc., a technology-first Randomization & Trial Supply Management company, is pleased to announce its collaboration with The Leukemia & Lymphoma Society on its innovative Beat AML® Master Clinical Trial.

Arsenal Biosciences, Inc. today announced that it will present preclinical data on its integrated circuit T cell therapies, AB-1015 and AB-2100, in an oral abstract session and three posters at the American Society of Gene and Cell Therapy (ASGCT) annual meeting in Los Angeles, Calif., May 16-20, 2023.

The Foundation for the National Institutes of Health announces the Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium has selected eight rare diseases for its clinical trial portfolio.

ElevateBio, LLC today announced four poster presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting taking place May 16-20, 2023, in Los Angeles, CA.